Soleus Capital Management

Soleus Capital Management is an active healthcare investment firm focused on innovative areas of life sciences including biotech, medtech, diagnostics, and genomics. The firm invests in both private and public companies across the healthcare lifecycle from developmental-stage through commercial-stage companies.

It manages multiple funds and has a track record of investing in mid to late-stage private companies as well as public equities. Its portfolio includes investments in leading biotech and medtech firms such as Staar Surgical Co., TG Therapeutics Inc., Beta Bionics Inc., Krystal Biotech Inc., NovoCure Ltd., BioMarin Pharmaceutical among others.

The company was founded in 2018 and operates out of Greenwich, Connecticut.

Key people include Guy Levy (Chief Investment Officer) and Greg Dryer (Director of Marketing & Investor Relations).

As an investor rather than a product developer or manufacturer itself, it does not have its own clinical pipeline or therapeutic programs.

Assets under management were reported at approximately $1.39 billion as of March 2025.

The company manages both hedge funds and private equity vehicles focused exclusively on the healthcare sector.

It has closed at least four funds since inception with recent closings in February 2024 and March 2023.